Ptc Therapeutics Inc. is a biopharmaceutical company engaged in the discovery, development, and commercialization of medicines focusing on rare genetic disorders. The primary objective of Ptc Therapeu... Ptc Therapeutics Inc. is a biopharmaceutical company engaged in the discovery, development, and commercialization of medicines focusing on rare genetic disorders. The primary objective of Ptc Therapeutics is to provide innovative treatments addressing unmet medical needs through novel therapies. The company is notable for its emphasis on utilizing its proprietary technologies, such as the Translarna technology, which targets genetic disorders caused by a particular type of mutation known as a "nonsense mutation." This strategic focus allows it to create disease-modifying therapies that significantly enhance patients' quality of life. In addition to genetic disorders, Ptc Therapeutics is active in the oncology and metabolic disease sectors, exploring a broad range of conditions. With its headquarters located in the United States, Ptc Therapeutics operates globally, collaborating with research institutes and industry partners to accelerate drug development. This company plays a significant role in the biopharmaceutical market through its commitment to advancing scientific research and offering hope to patients afflicted with rare genetic conditions by providing much-needed therapeutic options.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Greenhouse Gas (GHG) Emissions data disclosed by PTC Therapeutics

We reviewed PTC Therapeutics's website and available disclosure materials for the 2024 reporting period and did not identify any reported Greenhouse Gas (GHG) Emissions data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review PTC Therapeutics's data?

Create a free Tracenable account to signal interest in having our team review data for PTC Therapeutics.

Legal Center Contact Us